The best treatment for breast cancer is chemotherapy.
BREAK IT DOWN: More women with breast cancer can skip this once-standard treatment, according to a new study. “Until now, we’ve known that women with hormonally driven breast cancer who are classified as low-risk didn’t need chemotherapy, while women who were high-risk did. We weren’t sure about the intermediates. But a new trial called TAILORx found that most intermediates also got no significant benefit from chemotherapy,” Dr Hamilton shares. “The results will likely save 60,000 patients a year from receiving chemo.” That means avoiding many side effects, such as damage to heart and lung cells, hair loss and nausea. It’s a big win for personalised medicine, she says. “We’re constantly developing new therapies, and now we’re getting better at determining who needs exactly which treatments.”